Table 1.
Demographic and clinical findings. Hospital Tobon Uribe, 2007–2012
| Total |
Positive |
Negative |
||||
|---|---|---|---|---|---|---|
| Count | % | Count | % | Count | % | |
| Total | 2039 | 100·0 | 737 | 100·0 | 1302 | 100·0 |
| Gender | ||||||
| Female | 919 | 45·1 | 322 | 43·7 | 597 | 45·9 |
| Male | 1120 | 54·9 | 415 | 56·3 | 705 | 54·1 |
| Age group (yrs) | ||||||
| Mean ± SD | 5·2 ± 8 | 6·4 ± 8·3 | 4·5 ± 7·8 | |||
| Median [range] | 3 [0–76] | 4 [0–70] | 2 [0–76] | |||
| N valid | 2037 | 737 | 1300 | |||
| 0–4 | 1364 | 66·9 | 404 | 54·8 | 960 | 73·7 |
| 5–14 | 551 | 27·0 | 286 | 38·8 | 265 | 20·4 |
| 15–29 | 64 | 3·1 | 21 | 2·8 | 43 | 3·3 |
| 30–44 | 40 | 2·0 | 20 | 2·7 | 20 | 1·5 |
| 45–59 | 12 | 0·6 | 3 | 0·4 | 9 | 0·7 |
| 60+ | 6 | 0·3 | 3 | 0·4 | 3 | 0·2 |
| Missing | 2 | 0·1 | 0 | 0·0 | 2 | 0·2 |
| n/N | % | n/N | % | n/N | % | |
|---|---|---|---|---|---|---|
| Travelers in the past 15 days | 47/1978 | 2·4 | 21/720 | 2·9 | 26/1258 | 2·1 |
| Influenza vaccination | 133/1915 | 6·9 | 48/691 | 6·9 | 85/1224 | 6·9 |
| Current illness | ||||||
| Medical attention before enrollment | 829/1816 | 45·6 | 299/650 | 46·0 | 530/1166 | 45·5 |
| Treatment | ||||||
| Antibiotics | 473 | 23·2 | 138 | 18·7 | 335 | 25·7 |
| Antiviral | 9 | 0·4 | 6 | 0·8 | 3 | 0·2 |
| Antibiotics/antiviral | 6 | 0·3 | 0 | 0·0 | 6 | 0·5 |
| No | 1462 | 71·7 | 564 | 76·5 | 898 | 69·0 |
| Missing | 89 | 4·4 | 29 | 3·9 | 60 | 4·6 |
| n/N | % | n/N | % | n/N | % | P value | |
|---|---|---|---|---|---|---|---|
| Clinical findings* | |||||||
| Cough | 1895/2039 | 92·9 | 685/737 | 92·9 | 1210/1302 | 92·9 | >0·05 |
| Malaise/asthenia | 1556/2038 | 76·3 | 607/737 | 82·4 | 949/1301 | 72·9 | <0·001 |
| Rhinorrhea | 1311/2037 | 64·4 | 442/737 | 60·0 | 869/1300 | 66·8 | 0·002 |
| Pharyngeal erythema | 814/1836 | 44·3 | 336/692 | 48·6 | 478/1144 | 41·8 | 0·005 |
| Rhonchi | 531/2038 | 26·1 | 175/737 | 23·7 | 356/1301 | 27·4 | >0·05 |
| Wheezing | 469/2038 | 23·0 | 127/737 | 17·2 | 342/1301 | 26·3 | <0·001 |
| Dyspnea | 339/1836 | 18·5 | 72/692 | 10·4 | 267/1144 | 23·3 | <0·001 |
| Headache | 330/2037 | 16·2 | 169/737 | 22·9 | 161/1300 | 12·4 | <0·001 |
| Vomit | 286/1836 | 15·6 | 103/692 | 14·9 | 183/1144 | 16·0 | >0·05 |
| Sore throat | 293/2037 | 14·4 | 133/737 | 18·0 | 160/1300 | 12·3 | <0·001 |
| Polypnea | 263/1836 | 14·3 | 57/692 | 8·2 | 206/1144 | 18·0 | <0·001 |
| Conjunctival irritation | 290/2038 | 14·2 | 134/737 | 18·2 | 156/1301 | 12·0 | <0·001 |
| Myalgias | 204/2037 | 10·0 | 112/737 | 15·2 | 92/1300 | 7·1 | <0·001 |
| Rales | 175/1836 | 9·5 | 38/692 | 5·5 | 137/1144 | 12·0 | <0·001 |
| Abdominal pain | 166/1836 | 9·0 | 90/692 | 13·0 | 76/1144 | 6·6 | <0·001 |
| Adenopathy | 164/1836 | 8·9 | 59/692 | 8·5 | 105/1144 | 9·2 | <0·001 |
| Expectoration | 161/1835 | 8·8 | 53/692 | 7·7 | 108/1143 | 9·4 | >0·05 |
| Diarrhea | 104/1836 | 5·7 | 43/692 | 6·2 | 61/1144 | 5·3 | >0·05 |
*
Those with <5% were excluded.